MedPath

STRONG for Surgery & Strong for Life - Intensive Prehabilitation for Risk Reduction in Ventral Hernia Repair

Not Applicable
Recruiting
Conditions
Ventral Hernia
Surgery
Risk Reduction
Lifestyle
Postoperative Complications
Prehabilitation
Interventions
Behavioral: Prehabilitation (the STRONG programme)
Registration Number
NCT06611462
Lead Sponsor
Bispebjerg Hospital
Brief Summary

The five risky lifestyles Smoking, Nutrition (obesity and malnutrition), risky Alcohol intake, and Physical inactivity (SNAP) are common in surgical patients and associated with worse postoperative outcomes. Mono-factor interventions targeting and improving these risky lifestyles have been shown to reduce the risk at surgery, but there is a lack of systematic assessment of all five lifestyles of the patient before surgery and related optimization.

This study aims to evaluate the effect of intensive combined lifestyle interventions (the STRONG programme) compared with treatment as usual in patients undergoing ventral hernia repair on postoperative complications, health, and costs on short and longer term.

The hypothesis is that the STRONG programme will halve the complication rates within 30 days.

Detailed Description

This study is a multicentre randomised controlled trial. A total of 400 participants with one or more of the five risky SNAP lifestyles will be randomised to either the STRONG programme (a prehabilitation intervention) or treatment as usual preoperatively (control). The STRONG programme is individually tailored to the needs of the participants. The program contains education, motivational, and pharmaceutical support. All participants will be followed up at the end of the intervention/at surgery, one, three, and six months after surgery. Long-term outcomes are followed up from national registers two years after surgery.

Interim analysis will be employed.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Participants ≥18 years scheduled for ventral hernia repair (defect smaller than 8cm)
  • Enough time for at least 4 weeks of prehabilitation
  • Screened positive for at least 1 risky SNAP factor
  • Signed informed consent
Exclusion Criteria
  • Ventral hernia repairs with defect larger than 8 cm
  • Pregnancy/breastfeeding
  • Allergy/other contradiction to pharmaceutical and/or nutritional support
  • Contradiction to exercise
  • Previous complicated alcohol withdrawal symptoms (delirium or seizures)
  • Not able to participate in intervention due to psychiatric ilness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PrehabilitationPrehabilitation (the STRONG programme)Intervention (the STRONG programme): At least six counselling sessions (around one per week) prior to surgery as an integrated prehabilitation programme tailored to the individual patient's need for risk reduction at surgery based on a baseline screening for risky SNAP factors. It is delivered via the surgical "Engage in the process of change". The smoking cessation intervention follows the Gold Standard Programme and a similar structure has been used for alcohol cessation, physical exercise, and nutrition interventions. All participants in the intervention group will receive immunonutrition in the days before surgery.
Primary Outcome Measures
NameTimeMethod
Postoperative complications within 30 days30 days

Number and proportion of participants with at least one postoperative complication defined by requiring treatment

Secondary Outcome Measures
NameTimeMethod
Postoperative complications within 3 and 6 months3 months, 6 months

Number and proportion of participants with at least one postoperative complication defined by requiring treatment

Comprehensive Complication Index (CCI)30 days, 3 months, 6 months

Calculated from the Clavien-Dindo classification of the postoperative complications

Successful quitting of risky lifestylesEnd of intervention/at surgery, 30 days, 3 months, 6 months

Number and proportion of participants without all of their preoperative risky lifestyles (identified at baseline). Successful quitting of risky lifestyles are defined as:

* Smoking: no use of any tobacco products

* Malnutrition: not at risk of malnutrition defined as NRS \<3

* Obesity: 5-10 % loss of body fat mass compared to baseline

* Alcohol: Zero alcohol intake at end of intervention/surgery and below risky limits (\<14 units per week) at postoperative follow-ups

* Physical inactivity: being physically active at least 3.5 hours per week

Any improvement of risky lifestylesEnd of intervention/at surgery, 30 days, 3 months, 6 months

Number and proportion of participants with any improvement of any of their risky lifestyles compared with baseline. Any improvements include:

* Smoking: a reduced number of cigarettes

* Malnutrition: improvement in level of malnutrition (NRS scale)

* Obesity: any loss of body fat mass

* Alcohol: a reduced alcohol intake weekly (reduced number of units weekly)

* Physical inactivity: Any improvement in minutes of daily physical activity

Health-Related Quality of Life (HRQoL)End of intervention/at surgery, 30 days, 3 months, 6 months

Number and proportion of patients with improvement of HRQoL compared with baseline. HRQoL is measured by the EQ-5D instrument

Costs30 days, 6 months, 2 years

Measured as individual direct and indirect healthcare costs per patient based on data from national registries

Cost-effectiveness2 years

Calculated as a probability in percent (%)

Patient expectationsBaseline

Measured as a number on a VAS scale from 0-10

Patient reflections 1Baseline

Qualitative analysis of patients reflections on advantages and disadvantages of changing or continuing current lifestyle

Patient reflections 2Baseline

Qualitative analysis of patient reflections obtained from semi-structured interviews

Trial Locations

Locations (3)

Copenhagen University Hospital at Herlev

🇩🇰

Herlev, Denmark

Holbaek Sygehus

🇩🇰

Holbæk, Denmark

Zealand University Hospital

🇩🇰

Køge, Denmark

© Copyright 2025. All Rights Reserved by MedPath